17 Followers on Owler

Vivaldi Biosciences

Read more
Douglass Given's photo - CEO of Vivaldi Biosciences

CEO

Douglass Given

CEO Approval Rating

70/100

Founded:

07/2006

Status:

PrivateIndependent Company

Est. Annual Revenue
$15M
Agree?
Est. Employees
49
Agree?
Sector

Update Industry

VIVALDI BIOSCIENCES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Vivaldi Biosciences's company profile
Douglass Given's photo - CEO of Vivaldi Biosciences

Douglass Given

CEO

70/100
49
$23M
$15M
View Profile
1
Vivaldi Biosciences's Competitor - Vaxart logo
Andrei Floroiu's photo - President & CEO of Vaxart

Andrei Floroiu

President & CEO

87/100
34
$62.9M
$1.2M
View Profile
2
Vivaldi Biosciences's Competitor - MedImmune logo
CEO Avatar

CEO

- -
4,300
- -
$422.2M
View Profile
3
Vivaldi Biosciences's Competitor - Flexus Biosciences logo
Terry Rosen's photo - CEO of Flexus Biosciences

Terry Rosen

CEO

69/100
33
$40.2M
$3M
View Profile
4
Vivaldi Biosciences's Competitor - FluGen logo
Paul Radspinner's photo - President & CEO of FluGen

Paul Radspinner

President & CEO

86/100
20
$53.7M
$1.2M
View Profile
5
Vivaldi Biosciences's Competitor - Altimmune logo
Vipin K. Garg's photo - President & CEO of Altimmune

Vipin K. Garg

President & CEO

86/100
27
$220.6M
$6.2M
View Profile
6
Vivaldi Biosciences's Competitor - Inovio logo
Joseph J. Kim's photo - President & CEO of Inovio

Joseph J. Kim

President & CEO

69/100
281
$296.4M
$6.5M
View Profile
7
Vivaldi Biosciences's Competitor - Igenica logo
Robert Schreiber's photo - Co-Founder of Igenica

Robert Schreiber

Co-Founder

78/100
30
$58.1M
$3.8M
View Profile
8
Vivaldi Biosciences's Competitor - Visterra logo
Brian J. G. Pereira's photo - President & CEO of Visterra

Brian J. G. Pereira

President & CEO

90/100
90
$144.5M
$3M
View Profile
9
Vivaldi Biosciences's Competitor - TechnoVax logo
CEO Avatar

Jose Galarza

President & CEO

69/100
46
$509.6K
$10.4M
View Profile
10
Vivaldi Biosciences's Competitor - BioDiem logo
Julie Phillips's photo - CEO of BioDiem

Julie Phillips

CEO

70/100
45
- -
$10M
View Profile
11
Vivaldi Biosciences's Competitor - TVAX logo
CEO Avatar

Lowell L. Tilzer

Interim-CEO

71/100
29
$12.9M
$6.3M
View Profile
12
Vivaldi Biosciences's Competitor - Amgen logo
Robert A. Bradway's photo - Chairman & CEO of Amgen

Robert A. Bradway

Chairman & CEO

66/100
19,200
$4.1B
$26.7B
View Profile

Missing a competitor? Contribute!

Vaxart is Vivaldi Biosciences's biggest rival. Vaxart was founded in 2004, and is headquartered in South San Francisco, California. Vaxart competes in the Biotechnology industry. Vaxart generates $13.8M less revenue vs. Vivaldi Biosciences.

MedImmune is one of Vivaldi Biosciences's top competitors. MedImmune's headquarters is in Gaithersburg, Maryland, and was founded in 1988. MedImmune operates in the Health Care Technology industry. MedImmune generates 2,809% of Vivaldi Biosciences's revenue.

Flexus Biosciences is seen as one of Vivaldi Biosciences's top competitors. Flexus Biosciences is a Private company that was founded in 2013 in San Carlos, California. Flexus Biosciences is in the Biotechnology field. Compared to Vivaldi Biosciences, Flexus Biosciences has 16 fewer employees.

Vivaldi Biosciences Acquisitions

No recent acquisitions found related to Vivaldi Biosciences

Vivaldi Biosciences Funding History

Since Vivaldi Biosciences was founded in 07/2006, it has participated in 1 round of funding. In total Vivaldi Biosciences has raised $23.0M. Vivaldi Biosciences' funding round was on Jan 2009 for a total of $23.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Jan 2009
$23M

Since Vivaldi Biosciences was founded in 07/2006, it has participated in 1 round of funding. In total Vivaldi Biosciences has raised $23.0M. Vivaldi Biosciences' funding round was on Jan 2009 for a total of $23.0M

Vivaldi Biosciences Investments

No recent investments found related to Vivaldi Biosciences

Vivaldi Biosciences News

Vivaldi Biosciences Press Releases

Social Media

Vivaldi Biosciences Headquarters

462 1st Ave Building A, 9th Floor

New York, New York10016

646‐381‐6680

Driving Directions »

Trending Companies

Vivaldi Biosciences Summary

ABOUT

Overview

Vivaldi Biosciences is developing a more effective seasonal flu vaccine addressing the unmet needs of adults age 50 and older. Vivaldi Biosciences was founded in 07/2006. Vivaldi Biosciences' headquarters is located in New York, New York, USA 10016. I...

CEO

Vivaldi Biosciences's CEO, Douglass Given, currently has an approval rating of 70%. Vivaldi Biosciences's primary competitors are Vaxart, MedImmune & Flexus Biosciences.

Frequently Asked Questions about Vivaldi Biosciences

  1. When was Vivaldi Biosciences founded?

    Vivaldi Biosciences was founded in 07/2006
  2. Who is Vivaldi Biosciences's CEO?

    Vivaldi Biosciences's CEO is Douglass Given
  3. How much revenue does Vivaldi Biosciences generate?

    Vivaldi Biosciences generates $15M in revenue
  4. How much funding does Vivaldi Biosciences have?

    Vivaldi Biosciences has historically raised $23M in funding
  1. Where is Vivaldi Biosciences's headquarters?

    Vivaldi Biosciences's headquarters is in New York New York, USA
  2. How many employees does Vivaldi Biosciences have?

    Vivaldi Biosciences has 49 employees
  3. Who are Vivaldi Biosciences's competitors?

    Vivaldi Biosciences's top competitors are Vaxart, MedImmune, Flexus Biosciences